Dolutegravir
135 results
1 - 100
Dolutegravir- INDICATIONS
- FORMS
- References
- USUAL ADULT DOSING
- PEDIATRIC DOSING
- RENAL DOSING
- DOSING FOR GLOMERULAR FILTRATION OF 50-80
- DOSING FOR GLOMERULAR FILTRATION OF 10-50
- DOSING FOR GLOMERULAR FILTRATION OF < 10 ML/MIN
- DOSING IN HEMODIALYS
- DOSING IN PERITONEAL DIALYSIS
- DOSING IN HEMOFILTRATION
- ADVERSE DRUG REACTIONS
- DRUG INTERACTIONS
- RESISTANCE
- PHARMACOLOGY
- MECHANISM
- PHARMACOKINETIC PARAMETERS
- DOSING FOR DECREASED HEPATIC FUNCTION
- PREGNANCY RISK
- BREAST FEEDING COMPATIBILITY
- COMMENTS
Dolutegravir- INDICATIONS
- FORMS
- References
- USUAL ADULT DOSING
- PEDIATRIC DOSING
- RENAL DOSING
- DOSING FOR GLOMERULAR FILTRATION OF 50-80
- DOSING FOR GLOMERULAR FILTRATION OF 10-50
- DOSING FOR GLOMERULAR FILTRATION OF < 10 ML/MIN
- DOSING IN HEMODIALYS
- DOSING IN PERITONEAL DIALYSIS
- DOSING IN HEMOFILTRATION
- ADVERSE DRUG REACTIONS
- DRUG INTERACTIONS
- RESISTANCE
- PHARMACOLOGY
- MECHANISM
- PHARMACOKINETIC PARAMETERS
- DOSING FOR DECREASED HEPATIC FUNCTION
- PREGNANCY RISK
- BREAST FEEDING COMPATIBILITY
- COMMENTS
- Diabetes Mellitus and Insulin Resistance
- Raltegravir
- Raltegravir
- Retroviral Syndrome, Acute
- Retroviral Syndrome, Acute
- Nelfinavir
- Nelfinavir
- Pregnancy and perinatal transmission
- Tuberculosis, Active
Metformin- Initial Regimen
- Tuberculosis, Latent
- Etravirine (ETR)
- Etravirine (ETR)
- Antiretroviral Therapy: Treatment-Experienced Patients
- Bictegravir
- Bictegravir
- HIV Solid Organ Transplant Candidate/Recipient
- Hepatotoxicity
- Virologic failure: When to modify therapy
- HIV, Occupational Exposure
- HIV, Occupational Exposure
- Cabotegravir + Rilpivirine
- Rifapentine
- Elbasvir/Grazoprevir